[Skip to Content]
[Skip to Content Landing]
Views 2,326
Citations 0
Research Letter
August 25, 2020

Therapies Offered at Residential Addiction Treatment Programs in the United States

Author Affiliations
  • 1Department of Health Policy and Management, Yale University, New Haven, Connecticut
  • 2Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
  • 3Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Boston, Massachusetts
  • 4Department of Medicine, Massachusetts General Hospital, Boston
  • 5Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts
JAMA. 2020;324(8):804-806. doi:10.1001/jama.2020.8969

Residential treatment programs are a common, costly setting for treating opioid use disorder1 and are frequently promoted in policy proposals to improve access to care.2 However, concerns have been raised about the quality of care and low use of evidence-based opioid agonist treatment (OAT) in these settings.3 Most data available on programs come from self-reported surveys4 that may not reflect patient experience, so we simulated patient calls to audit treatments offered by programs nationally.